JPMorgan Chase & Co. Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its target price upped by research analysts at JPMorgan Chase & Co. from $72.00 to $78.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates […]
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its target price upped by research analysts at JPMorgan Chase & Co. from $72.00 to $78.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates […]
